Coronary Stent Thrombosis in the Current Drug-Eluting Stent Era: Insights From the ERACI III Trial

Furthermore, in those studies, stent thrombosis (SET) was not equal and appropriately defined; more importantly, none of the cited studies included SET as a prespecified end point. [...]we sought to investigate the incidence of SET in a DES population (9) included prospectively in the multicenter and controlled Argentine Randomized Trial of Coronary Stents versus Bypass Surgery (ERACI III) trial. [...]both DES designs had similar incidence of SET (1.9% with SES and 1.5% with PES).